BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 16776647)

  • 21. Mechanisms of intermittent hypoxia induced hypertension.
    Bosc LV; Resta T; Walker B; Kanagy NL
    J Cell Mol Med; 2010 Jan; 14(1-2):3-17. PubMed ID: 19818095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of plasma osteopontin levels with coronary calcification evaluated by tomographic coronary calcium scoring.
    Aryan M; Kepez A; Atalar E; Hazirolan T; Haznedaroglu I; Akata D; Ozer N; Aksoyek S; Ovunc K; Ozmen F
    J Bone Miner Metab; 2009; 27(5):591-7. PubMed ID: 19365701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.
    Mangan SH; Van Campenhout A; Rush C; Golledge J
    Cardiovasc Res; 2007 Dec; 76(3):494-505. PubMed ID: 17706953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension.
    Okura T; Watanabe S; Kurata M; Manabe S; Koresawa M; Irita J; Enomoto D; Miyoshi K; Fukuoka T; Higaki J
    Hypertens Res; 2007 Apr; 30(4):335-40. PubMed ID: 17541212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of plasma ox-LDL and carotid IMT may represent useful markers for atherosclerosis and may represent potential targets for therapeutic interventions.
    Savoiu G; Drăgan S; Cristescu C; Serban C; Noveanus L; Ionescu D; Nicola T; Duicu O; Raducan A; Voicu M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):397-401. PubMed ID: 21491821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow-mediated vasodilatation of the brachial artery and intima-media thickness of carotid artery in never-treated subjects.
    Irace C; Fiaschi E; Cortese C; Gnasso A
    Int Angiol; 2006 Sep; 25(3):274-9. PubMed ID: 16878076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial dysfunction, intima-media thickness and coronary reserve in relation to risk factors and Framingham score in patients without clinical atherosclerosis.
    Campuzano R; Moya JL; García-Lledó A; Tomas JP; Ruiz S; Megías A; Balaguer J; Asín E
    J Hypertens; 2006 Aug; 24(8):1581-8. PubMed ID: 16877961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Augmentation index and carotid intima-media thickness are differently related to age, C-reactive protein and oxidized low-density lipoprotein.
    Kampus P; Kals J; Ristimäe T; Muda P; Ulst K; Zilmer K; Salonen RM; Tuomainen TP; Teesalu R; Zilmer M
    J Hypertens; 2007 Apr; 25(4):819-25. PubMed ID: 17351374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteopontin and carotid atherosclerosis in patients with essential hypertension.
    Kurata M; Okura T; Watanabe S; Fukuoka T; Higaki J
    Clin Sci (Lond); 2006 Nov; 111(5):319-24. PubMed ID: 16776647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation of atherosclerosis using carotid ultrasonography].
    Akasaka K; Takai R; Saito E; Kino S; Ito Y; Hasebe N; Sasajima T
    Rinsho Byori; 2010 Aug; 58(8):809-15. PubMed ID: 20860174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.
    Scatena M; Liaw L; Giachelli CM
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2302-9. PubMed ID: 17717292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.
    Cho HJ; Cho HJ; Kim HS
    Curr Atheroscler Rep; 2009 May; 11(3):206-13. PubMed ID: 19361352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)-A Narrative Review.
    Kadoglou NPE; Khattab E; Velidakis N; Gkougkoudi E
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137398
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.